drugset / Trial / NCT03016598
Stimulant Oxytocin Study
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study will investigate the effects of intranasal administration of oxytocin, a social neuropeptide, on reducing stimulant use, enhancing therapeutic engagement, and susceptibility to stress-induced relapse in Veterans with stimulant use disorders and enrolled in opioid replacement therapy (ORT) program for co-occurring opioid use disorder (OUD).
Timeline
- Start
- 2018-01-26
- Primary completion
- 2020-02-14
- Completion
- 2020-02-14
Publications
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Oxytocin | Peptide | 40 iu | Intranasal |